TCA
MRK icon

Transcend Capital Advisors’s Merck MRK Stock Holding History

Transcend Capital Advisors’s Portfolio MRK Stock Details MRK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$31.6M Buy
262,384
+1,013
+0.4% +$117K 2.53% 3
2025
Q4 		$27.5M Sell
261,371
-7,109
-3% -$667K 2.13% 4
2025
Q3 		$22.5M Buy
268,480
+109
+0% +$8.98K 1.58% 8
2025
Q2 		$21.2M Sell
268,371
-6,261
-2% -$498K 1.64% 8
2025
Q1 		$24.7M Sell
274,632
-10,083
-4% -$941K 1.77% 7
2024
Q4 		$28.3M Sell
284,715
-9,344
-3% -$963K 2.04% 6
2024
Q3 		$33.4M Sell
294,059
-4,492
-2% -$534K 2.24% 4
2024
Q2 		$37M Buy
298,551
+4,102
+1% +$528K 2.68% 4
2024
Q1 		$38.9M Buy
294,449
+3,355
+1% +$414K 3.12% 4
2023
Q4 		$31.7M Buy
291,094
+475
+0.2% +$49.3K 2.82% 4
2023
Q3 		$29.9M Sell
290,619
-1,439
-0.5% -$155K 2.92% 4
2023
Q2 		$33.7M Buy
292,058
+2,212
+0.8% +$251K 3.21% 4
2023
Q1 		$30.8M Sell
289,846
-4,273
-1% -$461K 3.22% 3
2022
Q4 		$32.6M Sell
294,119
-2,899
-1% -$296K 3.55% 3
2022
Q3 		$25.6M Buy
297,018
+812
+0.3% +$72.5K 2.83% 3
2022
Q2 		$27M Buy
296,206
+201
+0.1% +$17.8K 2.81% 4
2022
Q1 		$24.3M Sell
296,005
-11,438
-4% -$902K 2.17% 4
2021
Q4 		$23.6M Buy
307,443
+2,087
+0.7% +$166K 2.08% 5
2021
Q3 		$25.1M Buy
+305,356
New +$23.2M 2.25% 7
2021
Q2 		– Sell
-325,409
Closed -$23.9M – 383
2021
Q1 		$23.9M Buy
325,409
+813
+0.3% +$60K 2.88% 4
2020
Q4 		$25.3M Buy
324,596
+16,791
+5% +$1.28M 3.33% 4
2020
Q3 		$24.4M Buy
307,805
+12,497
+4% +$979K 4.43% 4
2020
Q2 		$21.8M Sell
295,308
-4,341
-1% -$327K 7.09% 2
2020
Q1 		$22M Buy
299,649
+1,284
+0.4% +$101K 6.6% 2
2019
Q4 		$25.9M Buy
+298,365
New +$24.5M 6.97% 1

Other funds holding MRK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Transcend Capital Advisors's MRK Position: Q1 2026 in Review

Transcend Capital Advisors increased its Merck (MRK) stake by 0.39% in Q1 2026, buying an estimated $117K and bringing the position to 262,384 shares worth $31.6M. The position accounts for 2.53% of the portfolio, ranked #3.

Transcend Capital Advisors first reported a position in MRK in Q4 2019 and has held it in 25 quarters since. The position peaked at $38.9M in Q1 2024. 3,779 funds tracked by Wall St. Rank hold MRK as of Q1 2026.

  • Transcend Capital Advisors held 262,384 shares of Merck worth $31.6M as of Q1 2026.
  • Transcend Capital Advisors bought 1,013 Merck shares in Q1 2026, an estimated $117K.
  • Merck made up 2.53% of Transcend Capital Advisors's portfolio in Q1 2026, its #3 holding.
  • Transcend Capital Advisors first reported a position in Merck in Q4 2019 and has held it in 25 quarters since.
  • Transcend Capital Advisors's Merck position peaked at $38.9M in Q1 2024.
  • 3,779 funds tracked by Wall St. Rank held Merck as of Q1 2026.

Based on Transcend Capital Advisors's 13F filing for Q1 2026, filed 13 May 2026.